Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The Government has announced a pilot to test new ways to support patients living with obesity, in a bid to ease pressures on ...

When Eli Lilly (LLY) posted strong quarterly results, the stock fell from $750 to $625.65 by August 8. Shareholders fretted about clinical results from its next-generation obesity drug. Its 37.7% Y/Y ...

FAT jabs could be made available over the ­counter at pharmacies without the need for a GP to get involved. It is one idea ...

The Government has joined forces with the pharmaceutical giant that makes weight loss jab Mounjaro in a bid to tackle obesity ...

"Tirzepatide and other drugs like it, such as semaglutide, will help people living with obesity to lose weight, and as a ...

The mother's eyes turned yellow among other side effects while on Mounjaro, which had a devastating effect on her gallbladder ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 ...

A Cabinet minister has come under fire for saying he hopes Britons will use a new £85million NHS fat jabs trial to get ‘beach ready’ and ‘looking their best’.Peter Kyle said he wants the likes of ...

A wide variety of unapproved FDA drugs were discovered during inspections, including nearly 55,000 fake injectables and pills ...